US 11725043
Ulinastatin polypeptides
granted A61KA61K38/00A61K38/57
Quick answer
US patent 11725043 (Ulinastatin polypeptides) held by DiaMedica USA Inc. expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DiaMedica USA Inc.
- Grant date
- Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K38/00, A61K38/57, A61P, A61P1/18